For the purposes of section 57A(4) of the Act, the following particulars are prescribed—
(a) a statement by the analyst that he or she is an approved analyst within the meaning of section 57A of the Act; and
(b) a statement as to the method of analysis used; and
(c) a statement that a substance that is, or is capable of being, a drug for the purposes of the Act was present in the urine sample analysed; and
(d) the name of the substance found to be present in the urine sample analysed; and
(e) the concentration of the substance found to be present in the urine sample analysed; and
(f) the name and signature of the analyst; and
(g) the date on which the analysis was conducted; and
(h) a description of the contents of the identification label referred to in regulation 25(c) attached to the container in which the urine sample is placed.